Brief: Immunovia AB Appoints Jeff Borcherding As New CEO
April 29 (Reuters) - Immunovia AB (publ) IMMNOV.ST :
* IMMUNOVIA AB APPOINTS NEW CEO
* IMMUNOVIA - DECIDED TO APPOINT JEFF BORCHERDING, UNTIL NOW
PRESIDENT OF IMMUNOVIA'S US OPERATION, AS GLOBAL CEO REPLACING
PHILIPP MATTHIEU.
* IMMUNOVIA AB - PHILIPP MATHIEU WILL REMAIN AT BOARD OF
DIRECTORS' DISPOSAL DURING HIS NOTICE PERIOD, WHICH RUNS FOR SIX
MONTHS FROM TODAY'S DATE
*
Source text for Eikon: ID:nWkr27xbqD
Further company coverage: IMMNOV.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Immunovia AB (publ)
See all newsBrief: Immunovia Publishes Data On Pancreasure In Hereditary, Familial High-Risk Individuals
Brief: Immunovia To Carry Out Rights Issue Of About SEK 63 Million
Sweden's Immunovia Q2 sales rise on PancreaSure test uptake
Brief: Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million
Brief: PancreaSure Achieves 88% Sensitivity In Immunovia Study